Expertise in
3
conditions

Dr. Robert C. Bourge

Cardiology | Advanced Heart Failure and Transplant Cardiology
University Of Alabama Health Services Foundation, PC
619 19th St S, 
Birmingham, AL 
Accepting New Patients
Expertise in
3
conditions
University Of Alabama Health Services Foundation, PC
619 19th St S, 
Birmingham, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Bourge is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist in Birmingham, Alabama. Dr. Bourge is highly rated in 3 conditions, according to our data. His top areas of expertise are Heart Failure, Hypertension, Pulmonary Hypertension, Stent Placement, and Heart Transplant. Dr. Bourge is currently accepting new patients.

His clinical research consists of co-authoring 48 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Advanced Heart Failure and Transplant Cardiology
Licenses
Internal Medicine in AL
Hospital Affiliations
University Of Alabama Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION, PC
619 19th St S, Birmingham, AL 35249

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
Enrollment Status: Completed
Publish Date: November 01, 2024
Intervention Type: Drug
Study Drug: Treprostinil Inhalation Powder
Study Phase: Phase 1
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

48 Total Publications

Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring.
Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring.
Journal: Journal of cardiac failure
Published: May 12, 2022
Similar Doctors
Jose A. Tallaj
Expertise in
16
conditions
Dr. Jose A. Tallaj
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
16
conditions
Dr. Jose A. Tallaj
Advanced Heart Failure and Transplant Cardiology | Cardiology

University Of Alabama Health Services Foundation, PC

619 19th St S, 
Birmingham, AL 
 (0.1 miles away)
205-934-4011
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jose Tallaj is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Birmingham, Alabama. Dr. Tallaj is highly rated in 16 conditions, according to our data. His top areas of expertise are Heart Failure, Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Transplant, and Endoscopy. Dr. Tallaj is currently accepting new patients.

Expertise in
8
conditions
Dr. Andrew J. Lenneman
Cardiology | Advanced Heart Failure and Transplant Cardiology
Expertise in
8
conditions
Dr. Andrew J. Lenneman
Cardiology | Advanced Heart Failure and Transplant Cardiology

University Of Alabama Health Services Foundation, PC

619 19th St S, 
Birmingham, AL 
 (0.1 miles away)
205-934-4011
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andrew Lenneman is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist in Birmingham, Alabama. Dr. Lenneman is highly rated in 8 conditions, according to our data. His top areas of expertise are Heart Failure, Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Transplant, and Cardiac Ablation. Dr. Lenneman is currently accepting new patients.

Expertise in
23
conditions
Dr. Takumi Yamada
Cardiology | Cardiac Electrophysiology
Expertise in
23
conditions
Dr. Takumi Yamada
Cardiology | Cardiac Electrophysiology
619 19th St S, 
Birmingham, AL 
 (0.1 miles away)
205-934-4011
Languages Spoken:
English, Japanese
See accepted insurances
Accepting New Patients

Takumi Yamada is a Cardiologist and a Cardiac Electrophysiologist in Birmingham, Alabama. Dr. Yamada is highly rated in 23 conditions, according to our data. His top areas of expertise are Arrhythmias, Paroxysmal Supraventricular Tachycardia (PSVT), Ectopic Heartbeat, Cardiac Ablation, and Pacemaker Implantation. Dr. Yamada is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bourge's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile